![Tracy A. Sykes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tracy A. Sykes
Direktor/Vorstandsmitglied bei Transmed7 LLC
Profil
Tracy A.
Sykes is currently a Director at Transmed7 LLC.
Previously, Sykes worked as a Director at Rubicor Medical, Inc. and as a Partner at Robins Kaplan LLP.
Aktive Positionen von Tracy A. Sykes
Unternehmen | Position | Beginn |
---|---|---|
Transmed7 LLC
![]() Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Tracy A. Sykes
Unternehmen | Position | Ende |
---|---|---|
Robins Kaplan LLP
![]() Robins Kaplan LLP Miscellaneous Commercial ServicesCommercial Services Robins Kaplan LLP provides legal services. The firm offers services in the fields of business law, employment, merger, acquisition, consolidation, real estate, finance, and tax. The company was co-founded by Solly Robins and Julius E. Davis in 1938 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Rubicor Medical, Inc.
![]() Rubicor Medical, Inc. Medical SpecialtiesHealth Technology Encapsule Medical Devices LLC is a privately-held medical device company focused on the development and commercialization of minimally invasive breast biopsy and tissue removal technologies. The company is based in Redwood City, California. The Encapsule Medical team redefines breast care and ultimately changes the way physicians diagnose and treat breast cancer and benign breast disease. Encapsule Medical markets three breast care devices in the U.S. for the biopsy and removal of breast lesions. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Rubicor Medical, Inc.
![]() Rubicor Medical, Inc. Medical SpecialtiesHealth Technology Encapsule Medical Devices LLC is a privately-held medical device company focused on the development and commercialization of minimally invasive breast biopsy and tissue removal technologies. The company is based in Redwood City, California. The Encapsule Medical team redefines breast care and ultimately changes the way physicians diagnose and treat breast cancer and benign breast disease. Encapsule Medical markets three breast care devices in the U.S. for the biopsy and removal of breast lesions. | Health Technology |
Robins Kaplan LLP
![]() Robins Kaplan LLP Miscellaneous Commercial ServicesCommercial Services Robins Kaplan LLP provides legal services. The firm offers services in the fields of business law, employment, merger, acquisition, consolidation, real estate, finance, and tax. The company was co-founded by Solly Robins and Julius E. Davis in 1938 and is headquartered in Minneapolis, MN. | Commercial Services |
Transmed7 LLC
![]() Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Health Technology |